AR076732A1 - Formulaciones farmaceuticas elaboradas por nanoencapsulacion y/o complejacion - Google Patents
Formulaciones farmaceuticas elaboradas por nanoencapsulacion y/o complejacionInfo
- Publication number
- AR076732A1 AR076732A1 ARP090102671A ARP090102671A AR076732A1 AR 076732 A1 AR076732 A1 AR 076732A1 AR P090102671 A ARP090102671 A AR P090102671A AR P090102671 A ARP090102671 A AR P090102671A AR 076732 A1 AR076732 A1 AR 076732A1
- Authority
- AR
- Argentina
- Prior art keywords
- cyclodextrins
- beta
- nanoencapsulation
- complexation
- cyclodextrin
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/738—Cyclodextrins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4816—Wall or shell material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/10—General cosmetic use
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/56—Compounds, absorbed onto or entrapped into a solid carrier, e.g. encapsulated perfumes, inclusion compounds, sustained release forms
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Emergency Medicine (AREA)
- Oncology (AREA)
- Birds (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Dermatology (AREA)
- Virology (AREA)
- Dispersion Chemistry (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- Rheumatology (AREA)
- Psychiatry (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Compuestos elaborados por nanoencapsulacion y/o complejacion de los principios activos tales como integrantes de la familia de los jasmonatos, ciclopentanonas, sufasalaxina L-Arginina, coenzimas Q10 o CoQ10, Coenzima A. Reivindicacion 1: Compuestos elaborados por nanoencapsulacion y/o complejacion caracterizados porque comprenden como ingrediente activo integrantes de la familia de los jasmonatos, puros o no, conjugados o no con aminas (con substitucion del radical éster por un radical amina) nanoencapsulados en y/o complejados con (i) ciclodextrinas alfa, beta y gamma, ciclodextrinas modificadas o no, e incluyendo a las ciclodextrinas hidroxipropil-beta-ciclodextrina, beta-ciclodextrina metilada aleatoriamente, y sulfobutiléter beta-ciclodextrinas), (ii) liposomas compuestos de fosfatidil-colina, (iii) ácidos grasos y sus derivados, (iv) colesterol, modificado artificialmente o no, (v) polímeros biodegradables y absorbibles, (vi) dendrímeros, (vii) nanoesferas, (viii) talosferas, (ix) nanoemulsiones y (x) microemulsiones.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BRPI0804172-5A BRPI0804172A2 (pt) | 2008-07-15 | 2008-07-15 | compostos quìmicos formados a partir de nanoencapsulamentos e complexação de elementos |
Publications (1)
Publication Number | Publication Date |
---|---|
AR076732A1 true AR076732A1 (es) | 2011-07-06 |
Family
ID=41550752
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP090102671A AR076732A1 (es) | 2008-07-15 | 2009-07-15 | Formulaciones farmaceuticas elaboradas por nanoencapsulacion y/o complejacion |
Country Status (11)
Country | Link |
---|---|
US (2) | US20110305731A1 (es) |
EP (1) | EP2320879A4 (es) |
JP (5) | JP2011527989A (es) |
KR (2) | KR101751918B1 (es) |
CN (1) | CN102215832A (es) |
AR (1) | AR076732A1 (es) |
BR (1) | BRPI0804172A2 (es) |
CA (1) | CA2730876A1 (es) |
MX (1) | MX347677B (es) |
RU (1) | RU2011101961A (es) |
WO (1) | WO2010006392A2 (es) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BRPI0804172A2 (pt) * | 2008-07-15 | 2010-07-06 | Pereira Lopes Jose Emilio Fehr | compostos quìmicos formados a partir de nanoencapsulamentos e complexação de elementos |
AU2012221877A1 (en) * | 2011-02-25 | 2013-09-19 | Nanocare Technologies, Inc. | Pharmaceutical formulation comprising compounds of the jasmonate family |
JP2014526519A (ja) * | 2011-09-16 | 2014-10-06 | ナノケア テクノロジーズ,インコーポレイティド | ジャスモネート化合物の組成物および使用方法 |
WO2016109779A1 (en) | 2014-12-31 | 2016-07-07 | Nanocare Technologies, Inc. | Jasmonate derivatives and compositions thereof |
CN107551275B (zh) * | 2017-09-12 | 2020-06-12 | 山西大学 | 一种磁性纳米药物载体的制备及其负载盐酸阿霉素的方法 |
CN114171111B (zh) * | 2021-11-12 | 2024-06-28 | 中检科健(天津)检验检测有限责任公司 | 一种化学物质p-糖蛋白相互作用qsar筛选方法 |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69020408T2 (de) * | 1989-04-12 | 1996-01-04 | Procter & Gamble | Festes Verbraucherprodukt, welches feinteilige Cyclodextrin-Komplexe enthält. |
CA2013485C (en) * | 1990-03-06 | 1997-04-22 | John Michael Gardlik | Solid consumer product compositions containing small particle cyclodextrin complexes |
JP3568325B2 (ja) * | 1996-07-12 | 2004-09-22 | 株式会社ノエビア | 抗アンドロゲン剤及び養毛剤並びに毛髪用化粧料 |
JP3596835B2 (ja) * | 1996-08-13 | 2004-12-02 | 株式会社ノエビア | 養毛剤 |
EP0988025A1 (en) * | 1997-06-09 | 2000-03-29 | The Procter & Gamble Company | Perfumed compositions and methods for reducing body odors and excess moisture |
US6790815B1 (en) * | 1998-07-10 | 2004-09-14 | Procter & Gamble Company | Amine reaction compounds comprising one or more active ingredient |
CA2439953A1 (en) * | 2001-03-08 | 2002-09-19 | Mark D. Bednarski | Stabilized therapeutic and imaging agents |
US6469061B1 (en) * | 2001-04-04 | 2002-10-22 | Ramot University Authority For Applied Research And Industrial Development Limited | Jasmonate pharmaceutical composition for treatment of cancer |
US20030224024A1 (en) * | 2002-02-04 | 2003-12-04 | Jean-Luc Leveque | Compositions comprising cyclopentane derivatives and their use |
KR100789343B1 (ko) * | 2004-09-07 | 2007-12-28 | 주식회사 엘지생활건강 | 화장용 분체, 그의 제조방법 및 이를 함유하는 메이컵화장품 조성물 |
US7258878B2 (en) * | 2004-12-20 | 2007-08-21 | Kimberly-Clark Worldwide, Inc. | Anti-microbial composition and methods of use thereof |
ES2265291B1 (es) * | 2005-07-22 | 2008-03-01 | Universidad De Alcala | Nuevos dendrimeros carbosilanos, su preparacion y sus usos. |
WO2007103336A2 (en) * | 2006-03-06 | 2007-09-13 | The Board Of Trustees Operating | Micro-encapsulation of volatile compounds into cyclodextrins |
US20090185985A1 (en) * | 2006-06-13 | 2009-07-23 | Cargill, Incorporated | Large-particle cyclodextrin inclusion complexes and methods of preparing same |
JP2009542799A (ja) * | 2006-07-10 | 2009-12-03 | ラモト アット テル − アビブ ユニバーシティー リミテッド | 組合せ癌治療方法 |
BRPI0604024A (pt) * | 2006-09-01 | 2008-04-22 | Beyond Lifescience Pesquisa De | alimentos para a prevenção do cáncer e composições farmacêuticas à base do jasmonato |
BRPI0804172A2 (pt) * | 2008-07-15 | 2010-07-06 | Pereira Lopes Jose Emilio Fehr | compostos quìmicos formados a partir de nanoencapsulamentos e complexação de elementos |
-
2008
- 2008-07-15 BR BRPI0804172-5A patent/BRPI0804172A2/pt not_active IP Right Cessation
-
2009
- 2009-05-28 RU RU2011101961/15A patent/RU2011101961A/ru not_active Application Discontinuation
- 2009-05-28 CA CA2730876A patent/CA2730876A1/en not_active Abandoned
- 2009-05-28 EP EP09797284.8A patent/EP2320879A4/en not_active Withdrawn
- 2009-05-28 US US13/054,110 patent/US20110305731A1/en not_active Abandoned
- 2009-05-28 CN CN2009801263694A patent/CN102215832A/zh active Pending
- 2009-05-28 JP JP2011517717A patent/JP2011527989A/ja active Pending
- 2009-05-28 WO PCT/BR2009/000151 patent/WO2010006392A2/en active Application Filing
- 2009-05-28 KR KR1020117003309A patent/KR101751918B1/ko active IP Right Grant
- 2009-05-28 KR KR1020177017059A patent/KR20170076788A/ko not_active Application Discontinuation
- 2009-05-28 MX MX2011000400A patent/MX347677B/es active IP Right Grant
- 2009-07-15 AR ARP090102671A patent/AR076732A1/es not_active Application Discontinuation
-
2014
- 2014-08-01 JP JP2014157671A patent/JP2014237688A/ja active Pending
-
2016
- 2016-06-01 US US15/170,893 patent/US20160354312A1/en not_active Abandoned
- 2016-07-22 JP JP2016143999A patent/JP2016216496A/ja active Pending
-
2017
- 2017-09-29 JP JP2017189865A patent/JP2018030868A/ja active Pending
-
2019
- 2019-01-04 JP JP2019000267A patent/JP2019070008A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
US20110305731A1 (en) | 2011-12-15 |
MX347677B (es) | 2017-05-09 |
US20160354312A1 (en) | 2016-12-08 |
WO2010006392A3 (en) | 2010-03-18 |
JP2014237688A (ja) | 2014-12-18 |
WO2010006392A2 (en) | 2010-01-21 |
JP2016216496A (ja) | 2016-12-22 |
KR101751918B1 (ko) | 2017-06-30 |
EP2320879A4 (en) | 2014-03-05 |
MX2011000400A (es) | 2011-04-26 |
EP2320879A2 (en) | 2011-05-18 |
KR20170076788A (ko) | 2017-07-04 |
BRPI0804172A2 (pt) | 2010-07-06 |
JP2011527989A (ja) | 2011-11-10 |
KR20110031232A (ko) | 2011-03-24 |
JP2018030868A (ja) | 2018-03-01 |
RU2011101961A (ru) | 2012-08-20 |
JP2019070008A (ja) | 2019-05-09 |
CN102215832A (zh) | 2011-10-12 |
CA2730876A1 (en) | 2010-01-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR076732A1 (es) | Formulaciones farmaceuticas elaboradas por nanoencapsulacion y/o complejacion | |
CY1123901T1 (el) | Φαρμακευτικη συνθεση και χορηγησεις αυτης | |
MX346901B (es) | Formulaciones de solucion intravenosa de posaconazol estabilizadas mediante beta-ciclodextrina sustituida. | |
CY1115379T1 (el) | Μακροκυκλικοι αναστολεις της πρωτεασης σερινης της ηπατιτιδας c | |
Liu et al. | Inclusion complexation and solubilization of paclitaxel by bridged bis (β-cyclodextrin) s containing a tetraethylenepentaamino spacer | |
UY31870A (es) | Receptor metabotrópico de glutamato potenciadores 286 | |
Plazzo et al. | Uptake of a fluorescent methyl-β-cyclodextrin via clathrin-dependent endocytosis | |
WO2008009831A3 (fr) | Derives de cyclodextrines amphiphiles | |
BR112012000569B8 (pt) | composição compreendendo um conjugado de benzoato-hidrocodona (bz-hc) e composições para administração oral e intravenosa compreendendo o mesmo | |
GT201000144A (es) | " composiciones farmaceuticas " | |
NI201100158A (es) | Formulaciones de 4 - amino - 2 - (2, 6 - dioxopiperidina - 3 - il) isoindolina - 1, 3 - diona | |
GT200900329A (es) | Desodorante basado en propilenglicol/glicerina | |
MX2009011247A (es) | Nanoparticulas que comprenden una ciclodextrina y una molecula biologicamente activa y sus aplicaciones. | |
CY1113824T1 (el) | Ενδορινικες συνθεσεις | |
EP4289838A3 (en) | Arylmethoxy isoindoline derivatives and compositions comprising and methods of using the same | |
CR9703A (es) | Derivados de pirazolona | |
WO2011163483A3 (en) | Polymers for biomaterials and therapeutics | |
AR050717A1 (es) | Composiciones farmaceuticas | |
GB2484244A (en) | Anaesthetic formulation | |
CR9587A (es) | Derivados de piridazina | |
BR112015015609A2 (pt) | preparação de ésteres de poli alfa-1,3-glucano e seus filmes | |
ATE495176T1 (de) | Spiroindolinon-derivate | |
CY1114838T1 (el) | Φαρμακευτικες τοπικες συνθεσεις | |
NZ609356A (en) | Fast disintegrating compositions comprising nabilone and randomly methylated beta cyclodextrin | |
CY1116542T1 (el) | Νεα παραγωγα (συμπυκνωμενης ετεροκυκλο-πιπεριδινης)-(πιπεραζινυλ)-1-αλκανονης ή (συμπυκνωμενης ετεροκυκλο-πυρρολιδινης)-(πιπεραζινυλ)-1-αλκανονης, και χρηση αυτων ως αναστολεων p75 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal | ||
FB | Suspension of granting procedure |